Scarica l'app Stockscreener
21.75
1.02%
0.175
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie
Real time alert setup for Viridian Therapeutics Inc. performanceLong Setup & Technical Entry and Exit Alerts - newser.com
How Viridian Therapeutics Inc. stock reacts to bond yields2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Is Viridian Therapeutics Inc. (1S1) stock protected from inflationWeekly Trade Review & Safe Entry Momentum Stock Tips - newser.com
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Is Viridian Therapeutics Inc. stock dividend yield sustainableJuly 2025 Update & High Yield Stock Recommendations - newser.com
Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
Is Viridian Therapeutics Inc. stock safe for conservative investorsDay Trade & Capital Efficiency Focused Strategies - newser.com
Is Viridian Therapeutics Inc a good long term investmentHigh Frequency Trading Trends & In-Depth Analyst Ratings Explained Simply - earlytimes.in
Viridian Therapeutics: De-Risked Leadership In Thyroid Eye Disease (NASDAQ:VRDN) - Seeking Alpha
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.78 Consensus Target Price from Analysts - MarketBeat
Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Potential 93.73% Upside Amid Promising Clinical Trials - DirectorsTalk Interviews
A Look at Viridian Therapeutics’s Valuation Following Completion of Pivotal Phase III Trial Enrollment for VRDN-003 - Sahm
Dividend Watch: Can Viridian Therapeutics Inc. expand its profit marginsMarket Movers & Consistent Profit Focused Trading Strategies - خودرو بانک
Insider Trends: Is Viridian Therapeutics Inc stock a good pick for beginnersJobs Report & AI Optimized Trade Strategies - خودرو بانک
Is Viridian Therapeutics Inc. forming a reversal pattern2025 Year in Review & Momentum Based Trading Ideas - newser.com
Will Viridian Therapeutics Inc benefit from geopolitical trendsJuly 2025 EndofMonth & High Win Rate Trade Tips - خودرو بانک
VIX Spike: Should I hold or sell Viridian Therapeutics Inc nowTrade Ideas & Consistent Return Investment Signals - خودرو بانک
Aug Big Picture: What is Viridian Therapeutics Incs 5 year growth outlookEarnings Recap Report & AI Enhanced Trading Signals - خودرو بانک
Building trade automation scripts for Viridian Therapeutics Inc.Market Risk Summary & Technical Buy Zone Confirmations - newser.com
Quarterly Trades: Will Viridian Therapeutics Inc benefit from geopolitical trendsWeekly Trend Summary & Fast Entry Momentum Alerts - خودرو بانک
VIX Spike: What is Viridian Therapeutics Incs 5 year growth outlookSwing Trade & Technical Pattern Based Signals - khodrobank.com
Is Viridian Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Detecting support and resistance levels for Viridian Therapeutics Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Viridian Therapeutics Inc. stock prediction for this weekWeekly Stock Summary & Community Consensus Stock Picks - newser.com
Risk Analysis: What is the target price for Viridian Therapeutics Inc stockPrice Action & Reliable Breakout Forecasts - خودرو بانک
Published on: 2025-09-17 20:01:22 - خودرو بانک
Does Viridian Therapeutics Inc. qualify in momentum factor screeningQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
Hedge Fund Bets: What is CGONs 5 year growth outlookSwing Trade & Fast Entry High Yield Stock Tips - خودرو بانک
Aug Wrap: Should I add Viridian Therapeutics Inc. stock to my portfolio2025 Bull vs Bear & Proven Capital Preservation Methods - خودرو بانک
BTIG reiterates Buy rating on Viridian Therapeutic stock as trials complete enrollment - Investing.com Canada
Breakouts Watch: Can Viridian Therapeutics Inc withstand a market correctionWeekly Investment Recap & Fast Gain Stock Tips - خودرو بانک
Decliners Report: Can Viridian Therapeutics Inc. disrupt its industry2025 Stock Rankings & Low Risk High Reward Trade Ideas - خودرو بانک
Viridian Therapeutics, Inc. $VRDN Shares Sold by Alliancebernstein L.P. - MarketBeat
Weekly Recap: What are the future prospects of Viridian Therapeutics IncJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Viridian Therapeutics: Promising Pipeline and Strategic Advancements Justify Buy Rating - TipRanks
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates - BioSpace
Entry Recap: Can Viridian Therapeutics Inc. lead its sector in growthQuarterly Investment Review & Expert Approved Momentum Trade Ideas - خودرو بانک
Momentum Shift: Is BCGWW undervalued by DCF analysisJuly 2025 Reactions & Low Drawdown Momentum Ideas - خودرو بانک
Published on: 2025-09-15 21:50:00 - خودرو بانک
Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003 - Ophthalmology Times
Viridian Therapeutics announces completion of enrollment in both Reveal clinical trials and positive portfolio updates - MarketScreener
Viridian Therapeutics Announces Completion Of Enrollment In Both Reveal Clinical Trials And Positive Portfolio Updates - TradingView
Viridian Therapeutics (VRDN) Completes Enrollment for Key Phase 3 Trials - GuruFocus
Hedge Fund Bets: Can Viridian Therapeutics Inc. expand its profit margins2025 Top Decliners & Daily Volume Surge Signals - خودرو بانک
Octagon Capital Advisors LP Reduces Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Exome Asset Management LLC Invests $2.93 Million in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Yiheng Capital Management L.P. Cuts Stock Position in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Adage Capital Partners GP L.L.C. Sells 555,414 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat
Invesco Ltd. Acquires 14,672 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat
2.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):